Overcoming Viral Clearance Challenges: Many factors must be considered to overcome the challenges associated with viral clearance.
| Publicado en: | BioPharm International Vol. 37; no. 10; pp. 18 - 23 |
|---|---|
| Autor principal: | |
| Formato: | pictorial Journal Article |
| Publicado: |
MJH Life Sciences
Nov/Dec2024
|
| Acceso en línea: | Ver este registro en EBSCOhost |
| fields | @attributes: recordID: 1 pdfLink: plink: https://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=181258228&site=ehost-live header: @attributes: shortDbName: ccm uiTerm: 181258228 longDbName: CINAHL Complete uiTag: AN controlInfo: bkinfo: dissinfo: jinfo: jid: 1542166X 5NE jtl: BioPharm International issn: 1542166X maglogo: N pubinfo: dt: Nov/Dec2024 vid: 37 iid: 10 pid: 54670 pub: MJH Life Sciences place: Cranbury, New Jersey artinfo: ui: 181258228 181258228 181258228 181258228 ppf: 18 ppct: 5 formats: fmt: @attributes: type: P tig: atl: Overcoming Viral Clearance Challenges: Many factors must be considered to overcome the challenges associated with viral clearance. aug: au: CHALLENER, CYNTHIA A. sug: subj: Biological Products Drug Development Virus Inactivation Methods Pharmacy Service Pharmaceutical Companies Facility Design and Construction Leadership World Health Success Technology, Medical pubtype: Trade Publication doctype: pictorial Journal Article ougenre: Article ab: language: English refInfo: holdings: @attributes: islocal: N |
|---|